NASDAQ : COGT

Cogent Biosciences, Inc. — Earnings Estimates

$38.93 USD

-$2.43 (-5.88%)

Volume
1.55M
Average Volume
2.44M
Market Capitalization
$6.65B
P/E Ratio
-12.64
Dividend Yield
0.00%
Price Target
$48.50
Year High
$43.73
Year Low
$10.38
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$15.14

Annual earnings financials

COGT financial data with annual/quarterly toggle

COGT GAAP EPS - Annual & Quarterly

COGT Sales Revenue - Annual & Quarterly

COGT Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

COGT Estimated and Actual Revenue by Quarter
COGT Estimated and Actual EPS by Quarter
COGT Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2029-12-31 11 - - - - - -
2029-09-30 10 - - - - - -
2029-06-30 10 - - - - - -
2029-03-31 11 - - - - - -
2028-12-31 6 - - - - - -
2028-09-30 5 - - - - - -
COGT Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2029-12-31 11 64.29M 64.29M 64.29M - - -
2029-09-30 10 50.57M 50.57M 50.57M - - -
2029-06-30 10 38.16M 38.16M 38.16M - - -
2029-03-31 11 27.34M 27.34M 27.34M - - -
2028-12-31 6 16.98M 16.98M 16.98M - - -
2028-09-30 5 6.26M 6.26M 6.26M - - -
COGT Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2029-12-31 11 428.05M 428.05M 428.05M 6 0.9537 0.9537 0.9537
2029-09-30 10 375.12M 375.12M 375.12M 3 0.7501 0.7501 0.7501
2029-06-30 10 326.86M 326.86M 326.86M 5 0.5661 0.5661 0.5661
2029-03-31 11 284.28M 284.28M 284.28M 3 0.4055 0.4055 0.4055
2028-12-31 6 243.19M 243.19M 243.19M 7 0.2519 0.2519 0.2519
2028-09-30 5 200.26M 200.26M 200.26M 4 0.0928 0.0928 0.0928